Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retinoic Acid and Interferon-Alpha2a in Children With Immunodeficiency Syndromes and Lymphoproliferative Disorders
NCT00001438Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 1995
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tretinoin and interferon alfa-2a in lymphoproliferative disorders (LPD), sponsored by National Cancer Institute. Started Jun 1995; status: completed.
02
Drugs
tretinoininterferon alfa-2a
03
Conditions
lymphoproliferative disorders (LPD)
Beyond the preview
Go deeper on NCT00001438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001438.